Back

Impact of SGLT2 inhibitor on renal function and cardiovascular outcomes in heart failure: Korean heart failure III registry

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - pharmacotherapy (3) Pharmacotherapy HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Professor Eung Ju Kim

Korea University Guro Hospital, Seoul (Korea (Republic of))

8 More presentations in this session

Presentation thumbnail
Assessment of pharmacotherapy modifications during the treatment of episode of acutely decompensated heart failure - the HEROES study.
Doctor A. Galas (Warsaw, PL)
Abstract Slides Video
Presentation thumbnail
Vericiguat and reverse ventricular remodeling in patients with chronic HFrEF and recent heart failure worsening
Doctor T. Bajec (Ljubljana, SI)
Abstract Slides Video
Presentation thumbnail
Optimising heart failure therapy: potassium binders and the initiation and titration of mineralocorticoid receptor antagonists
Doctor T. Furlan (Trbovlje, SI)
Abstract Slides Video
Presentation thumbnail
Efficacy and safety of SGLT2 inhibitors in acute heart failure: a systematic review and meta-analysis of randomized controlled trials
Doctor S. Fox (Birmingham, GB)
Abstract Slides Video
Presentation thumbnail
Performance of mortality risk scores in advanced heart failure patients: a retrospective cohort study
Doctor C. Gregorio (Lisbon, PT)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in chronic heart failure - pharmacotherapy (3)

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Session
Further Insights into SGLT2i treatment for heart failure
thumbnail
Congress Session
Pharmacotherapy
thumbnail
Congress Session
Young Investigator Award (YIA) Clinical Cardiology

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources